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Summary.-Neutrophil function has been assessed in 62 patients with lympho-
reticular malignancy by means of the NBT test and an in vitro micro-organism
killing technique. Normal or enhanced phagocytosis was found, the greatest
enhancement being found in patients with disseminated disease (in the absence
of infections). Candicidal capacity alone was depressed in 7 patients but 4 of these
showed depressed cell-mediated immunity to Candida antigen. Splenectomy,
radiotherapy and chemotherapy did not alter phagocytic function.
LYMPHO-RETICULAR malignancy is
known to be associated with deficiency
of cell-mediated and humoral immunity.
However, little attention has been paid
to the function of the neutrophil. We
have studied phagocytic and killing func-
tion of peripheral neutrophils in patients
with Hodgkin's and non-Hodgkin's lym-
phoma.
There are many methods available
for the study of phagocyte function.
Cell mobilization to sites of inflammation
can be assessed in vivo by the skin
window technique (Rebuck and Crowley,
1955); chemotaxis by the micropore filter
technique (Boyden, 1962); enzyme sys-
tems involved in micro-organism killing
by in vitro methods such as HMP
shunt activity assessment (Keusch,
Douglas and Mildvan, 1972), nitroblue
tetrazolium (NBT) test (Park, Fikrig
and Smithwick, 1968) and myeloperoxi-
dase cytochemistry (Dacie and Lewis,
1970) and micro-organism killing power
by viable counting techniques (Miles and
Misra, 1938).
We selected the NBT test and an in
vitro micro-organism killing technique to
give an assessment of phagocytosis, en-
zyme system integrity and associated
killing power.
MATERIAL AND METHODS
Patients.-41 patients with Hodgkin's
disease and 21 withnon-Hodgkin'slymphoma
have been assessed at presentation. Twenty
of the Hodgkin's patients underwent diag-
nostic laparotomy with splenectomy; studies
were repeated in these patients 2-4 weeks
after operation.
Phagocytosis was re-assessed in 6 patients
immediately after their course of radio-
therapy and in 6 patients between their
third and fourth courses of quadruple
cytotoxic chemotherapy.
Method8.-Peripheral differential white
blood cell counts were performed at each
stage of assessment. The nitroblue tetra-
zolium (NBT) test used was the unstimulated
semiquantitative histochemical technique of
Park et al. (1968). Heparinized blood was
incubated with buffered 0.1% NBT solution.
Smears were made on glass slides and
counterstained. The percentage of neutro-
phils containing formazan deposits was
counted. Normally less than 10% ofneutro-
phils show reduction.
Killing capacity of neutrophils was asses-
sed by a simplified test modified from the
methods of Miles and Misra (1938) and
Quie et al. (1967).
Ten ml of venous blood was collected
from each patient into a sterile polypropylene
syringe containing 100 u of non-preserved
heparin (Weddel Pharmaceuticals). Tests
were commenced in all cases within 30 min
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of collection of blood and were always
compared with an assessment of blood from
a healthy control donor taken at the same
time and treated in the same way. To 6 ml
of blood, 0 5 ml of Dextran 110 in normal
saline (Fisons) was added to sediment red
blood cells. The leucocytes were then separ-
ated from the plasma by centrifugation (at
1000 rev/min for 5 min), washed in phosphate
buffered saline (PBS), recentrifuged and
then resuspended in PBS to give the original
volume. Leucocytes were counted prior to
and after separation. The yield of neutro-
phils after separation varied between 70 and
85% of the whole blood total.
Overnight broth cultures of Staphylo-
coccus albus, Diplococcu8 pneumoniae and
Candida albicans were plated in serial dilu-
tions on blood agar and incubated at 37°C
for 24 h to give a colony count. Thus, at
the time of plating, a known number of
organisms could be incubated with (i) 1 ml
of fresh whole blood, or (ii) 1 ml of fresh
washed leucocytes in PBS. After 1 h in-
cubation at 37°C the neutrophils were lysed
by distilled water and the preparations
plated in serial dilutions on blood agar.
Remaining viable organisms were thus esti-
mated from colony counting after incubation
for 24 h at 37°C. The test neutrophil count
was corrected against the control neutrophil
count and the neutrophil killing index for
each organism was expressed as a ratio to the
control kill, i.e.
Patient's micro-organism kill
Control micro-organism kill
The normal range (12 healthy volunteers,
8 of whom were tested at least twice) was
0-4-1-6 (overall mean 0 94 ± 0.07).
Statistical significance was assessed from
values of probability (P) from Student's
t-test.
RESULTS
The NBT score was normal or high
at presentation in all patients (Table I).
Eight Hodgkin's and 3 non-Hodgkin's
patients had high scores (10%) for NBT
reduction.
In killing tests no patient's leucocytes
had a bactericidal defect. Depressed
candicidal activity alone was noted in 6
Hodgkin's and 1 non-Hodgkin's lymphoma
patient. With the exception of these
results all patients showed normal or
enhanced killing ofmicro-organisms. Thir-
teen patients with Hodgkin's disease and
9 with non-Hodgkin's lymphoma showed
significant enhancement of overall killing
capacity (for whole blood and separated
leucocytes). All except 4 ofthese patients
had widespread disease and were staged
3B or 4 (Ann Arbor classification).
When the patients were assessed as
groups (Table I) high killing indices were
seen in all categories. Bacterial killing
indices were in general higher in the
non-Hodgkin's than in the Hodgkin's
lymphoma patients though the differen-
ces were significant only for separated
leucocytes. Significant enhancement
(P < 0.05) of overall micro-organism
killing was seen in both Hodgkin's disease
(with whole blood) and in non-Hodgkin's
lymphoma (whole blood and separated
leucocytes) compared with the healthy
control group.
Neutrophil counts were significantly
higher after splenectomy but NBT scores
and killing indices showed no change
(Table II).
Neutrophil counts were lower, though
not significantly so, after radiotherapy
and during chemotherapy but NBT scores
and killing indices showed no change
(Table III).
There was a positive correlation be-
tween NBT scores and phagocytic killing
indices (r 0.69).
DISCUSSION
Reticulo-endothelial system phagocy-
tosis, as measured by clearance of 1251-
labelled aggregated human serum albu-
min, is increased in Hodgkin's lymphoma,
advanced disease being associated with
more rapid, and remission with slower,
clearance rates (Sheagren, Block and
Wolff, 1967).
We have found normal or enhanced
phagocytosis and killing activity in the
peripheral neutrophils of patients with
lymphomata. The greatest enhancement
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TABLE II.-Neutrophil Phagocytic Function after Splenectomy
(20 Hodgkin's Patients)
Pre-splenectomy
Post-splenectomy
Neutrophil count/mm3
(mean±s.e.)
5890±560
9010± 1490*
NBT score %
(mean±s.e.)
7-2±0-9
8*8±2*2
Killing index (overall)
(mean±s.e.)
3*2±1*2
3-5±1 0
* Significant increase from prior value (P < 0 01).
TABLE III.-Neutrophil Function after Radiotherapy or during
Chemotherapy in Lymphoma Patients
Neutrophil count/mm3 NBT score % Killing index (overall)
(mean+s.e.) (mean+s.e.) (mean+s.e.)
Radiotherapy (6 patients)
Before therapy
After therapy
Chemotherapy (6 patients)
Before therapy
After therapy
4410+500
3807±360
4450+ 810
3050+ 810
5*6±0*8
6-5±0 7
11*4±4*6
8 7±2 8
1*3+0-1
1 5+0 3
3 9±2-6
3 5±0 9
of phagocytic function was seen- in
patients with disseminated disease. We
are unable to explain the apparent en-
hancement of bacterial killing power
(particularly with separated leucocytes)
in the non-Hodgkin's as compared with
Hodgkin's lymphoma patients. Defects
in bactericidal capacity were not found.
Candicidal activity alone, however, was
depressed in 6 patients with Hodgkin's
disease and 1 with non-Hodgkin's lym-
phoma. It is of interest that 4 of these
patients showed markedly depressed cell-
mediated immunity to Candida antigen
(both in in vitro techniques and by skin
testing). The defects in candicidal acti-
vity may therefore be related more to
the patients' defective cellular immune
response than to neutrophil abnormality.
Defective phagocytosis due to defi-
ciency of the phagocytosis-stimulating
peptide tuftsin has been demonstrated in
splenectomized subjects (Constantopoulos
et al., 1973) and immunosuppressive
chemotherapy may reduce the NBT
response (Lancet, 1974). However, in
our patients splenectomy, radiotherapy
and chemotherapy did not alter phago-
cytic function though the number of
circulating neutrophils changed.
We have not yet fully evaluated our
33
patients in remission but preliminary
results suggest that neutrophil phagocytic
function returns to normal in those
successfully treated patients with en-
hanced activity at presentation.
Enhanced NBT reduction may give
supportive evidence of bacterial infection
in previously healthy individuals (Park et
al., 1968). However, none ofour patients
with increased phagocytic and killing
capacity were overtly infected, and recent
reports have described non-specifically
high NBT scores in patients with cancer,
including lymphomata (Ashburn, Cooper
and McCall, 1973; Silverman and Read,
1973). Any attempt to detect bacterial
infection in malignancy by neutrophil
phagocytic assessment should therefore
be interpreted with caution.
As well as being complicated by the
patient's clinical status, the interpretation
of neutrophil function studies is often
difficult because of the variability of
laboratory methods and materials used.
It is recognized that even healthy volun-
teers show variations in bacterial killing
power (Miles and Misra, 1938).
Nevertheless it would appear from
our data that gross defects in neutrophil
function cannot be implicated in the
predisposition to infection known to be
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present in lymphoma. Probably of more
importance are the recognized defects in
immunity seen in disseminated disease
and after radiotherapy or cytotoxic che-
motherapy. If neutrophil phagocytic
function is enhanced, however, this may
provide supportive evidence ofwidespread
lymphomatous involvement, though the
mechanism of the enhanced function is as
yet unexplained.
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